Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo

被引：0
|
作者：
Guan Jiang
Chao Sun
Rong-Hua Li
Zhi-Ping Wei
Jun-Nian Zheng
Yan-Qun Liu
机构：
[1] Affiliated Hospital of Xuzhou Medical College,Department of Dermatology
[2] Xuzhou Medical College,Jiangsu Key Laboratory of Biological Cancer Therapy
[3] Center for Disease Control and Prevention of Xuzhou City,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2015年 / 141卷
关键词：
Melanoma; Interleukin 24; Ki67 promoter; Temozolomide; Oncolytic adenovirus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：75 / 85
页数：10
相关论文
共 50 条
  • [31] Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
    Ono, Ryosuke
    Takayama, Kosuke
    Sakurai, Fuminori
    Mizuguchi, Hiroyuki
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 20 : 399 - 409
  • [32] Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma
    Yang, Chunhua
    Cao, Hang
    Liu, Ning
    Xu, Kai
    Ding, Meng
    Mao, Li-jun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3755 - 3761
  • [33] Oncolytic adenovirus with low-dose temozolomide induces autophagy and antitumor immune responses preclinically and in cancer patients
    Liikanen, Ilkka
    Ahtiainen, Laura
    Hirvinen, Mari L. M.
    Barmante, Simona
    Cerullo, Vincenzo
    Nokisalmi, Petri
    Hemminki, Otto
    Diaconu, Iulia
    Pesonen, Sari
    Koski, Anniina
    Kangasniemi, Lotta
    Pesonen, Saila K.
    Oksanen, Minna
    Zhao, Fang
    Laasonen, Leena
    Partanen, Kaarina
    Joensuu, Timo
    Kanerva, Anna
    Hemminki, Akseli
    CANCER RESEARCH, 2013, 73 (08)
  • [34] Modulation of the efficacy of temozolomide and dacarbazine melanoma treatment by DNA-repair factors in vivo and in vitro
    Boeckmann, L.
    Thoms, K. -M.
    Gutzmer, R.
    Has, C.
    Kunz, M.
    Kuschal, C.
    Laspe, P.
    Struever, D.
    Emmert, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 (01) : 33 - 35
  • [35] Adenovirus-Retrovirus Hybrid Vectors Achieve Highly Enhanced Tumor Transduction and Antitumor Efficacy In Vivo
    Kubo, Shuji
    Haga, Kazunori
    Tamamoto, Atsuko
    Palmer, Donna J.
    Ng, Philip
    Okamura, Haruki
    Kasahara, Noriyuki
    MOLECULAR THERAPY, 2011, 19 (01) : 76 - 82
  • [36] ORCA-010, a Novel Potency-Enhanced Oncolytic Adenovirus, Exerts Strong Antitumor Activity in Preclinical Models
    Dong, Wenliang
    van Ginkel, Jan-Willem H.
    Au, Kam Y.
    Alemany, Ramon
    Meulenberg, Janneke J. M.
    van Beusechem, Victor W.
    HUMAN GENE THERAPY, 2014, 25 (10) : 897 - 904
  • [37] Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors
    Yamamoto, Yuki
    Nagasato, Masaki
    Rin, Yosei
    Henmi, Marina
    Ino, Yoshinori
    Yachida, Shinichi
    Ohki, Rieko
    Hiraoka, Nobuyoshi
    Tagawa, Masatoshi
    Aoki, Kazunori
    CANCER MEDICINE, 2017, 6 (10): : 2385 - 2397
  • [38] Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment Failure
    Cui, ChuanLiang
    Zhou, Li
    Lian, Bin
    Si, Lu
    Sheng, XiNan
    Chi, ZhiHong
    Kong, Yan
    Wang, Xuan
    Tang, BiXia
    Mao, LiLi
    Li, SiMing
    Dai, Jie
    Yan, XieQiao
    Bai, Xue
    Guo, Jun
    TRANSLATIONAL ONCOLOGY, 2018, 11 (05): : 1155 - 1159
  • [39] Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8+ T Cells
    Chen, Duo
    Huang, Luyu
    Zhou, Haiyu
    Zhang, Yuhui
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [40] Oncolytic Adenovirus Coexpressing Interleukin-12 and shVEGF Restores Antitumor Immune Function and Enhances Antitumor Efficacy
    Ahn, Hyo Min
    MOLECULAR THERAPY, 2017, 25 (05) : 158 - 158
12345